Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

By                    

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 167-170

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J.   Monnier A.   Riviere A.   Milleron B.   Lemarie E.   Trillet-Lenoir V.   Soussan-Lazard K.   Berille J.   Douillard J.Y.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

By Kwon Jung   Kim Jung   Lee Jung-Ae   Shin Hyun   Kim Hyo   Song Hun   Jung Joo   Kim Ho   Choi Dae   Kim Hyeong   Park Young-iee   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 889-897

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel (taxotere(R)) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer

By Le Chevalier T.   Monnier A.   Douillard J.Y.   Ruffie P.   Sun X.S.   Belli L.   Ibrahim N.   Bougon N.   Berille J.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2032-2036

Elsevier

Access to resources Recommend Favorite